Author:
Onakpoya Igho J,Spencer Elizabeth A,Thompson Matthew J,Heneghan Carl J
Reference34 articles.
1. Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products;Dear;Br J Clin Pharmacol,2006
2. Orphan drug: development trends and strategies;Sharma;J Pharm Bioallied Sci,2010
3. European Medicines Agency (EMA). Orphan drugs and rare diseases at a glance. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/01/WC500069805.pdf
4. National Institute for Clinical Excellence. NICE citizens council report ultra orphan drugs. London: NICE, 2004. http://www.nice.org.uk/proxy/?sourceUrl=http://www.nice.org.uk/niceMedia/pdf/boardmeeting/brdjan05item4.pdf (accessed 7 May 2015).
5. Drugs for exceptionally rare diseases: do they deserve special status for funding?;Hughes;QJM,2005
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献